First Time Loading...

Hisamitsu Pharmaceutical Co Inc
TSE:4530

Watchlist Manager
Hisamitsu Pharmaceutical Co Inc Logo
Hisamitsu Pharmaceutical Co Inc
TSE:4530
Watchlist
Price: 3 823 JPY 1.16% Market Closed
Updated: Apr 30, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

139.3B
+3%
Revenue
Growth Rates:
1 Year
+11%
3 Years
+13%
5 Years
-2%
7 Years
-7%
10 Years
-7%
15.2B
+2%
Operating Income
Growth Rates:
1 Year
+39%
3 Years
+22%
5 Years
-32%
7 Years
-43%
10 Years
-34%
14.3B
+5%
Net Income
Growth Rates:
1 Year
+11%
3 Years
+59%
5 Years
-14%
7 Years
-31%
10 Years
-38%

Earnings Waterfall
Hisamitsu Pharmaceutical Co Inc

Revenue
139.3B JPY
Cost of Revenue
-60.8B JPY
Gross Profit
78.5B JPY
Operating Expenses
-63.4B JPY
Operating Income
15.2B JPY
Other Expenses
-822m JPY
Net Income
14.3B JPY

Income Statement
Hisamitsu Pharmaceutical Co Inc

Rotate your device to view
Income Statement
Currency: JPY
Nov-2013 Feb-2014 May-2014 Aug-2014 Nov-2014 Feb-2015 May-2015 Aug-2015 Nov-2015 Feb-2016 May-2016 Aug-2016 Nov-2016 Feb-2017 May-2017 Aug-2017 Nov-2017 Feb-2018 May-2018 Aug-2018 Nov-2018 Feb-2019 May-2019 Aug-2019 Nov-2019 Feb-2020 May-2020 Aug-2020 Nov-2020 Feb-2021 May-2021 Aug-2021 Nov-2021 Feb-2022 May-2022 Aug-2022 Nov-2022 Feb-2023 May-2023 Aug-2023 Nov-2023
Revenue
Revenue
150 544
N/A
150 635
+0%
151 326
+0%
150 305
-1%
150 446
+0%
156 743
+4%
158 667
+1%
162 119
+2%
164 086
+1%
161 852
-1%
160 325
-1%
153 871
-4%
149 298
-3%
145 925
-2%
143 853
-1%
144 941
+1%
145 749
+1%
148 466
+2%
145 892
-2%
144 403
-1%
141 500
-2%
143 408
+1%
139 147
-3%
137 422
-1%
139 912
+2%
140 992
+1%
136 641
-3%
130 517
-4%
122 736
-6%
114 510
-7%
117 389
+3%
120 135
+2%
120 351
+0%
120 193
0%
118 825
-1%
121 261
+2%
125 411
+3%
128 330
+2%
134 033
+4%
135 688
+1%
139 276
+3%
Gross Profit
Cost of Revenue
(54 413)
(55 471)
(55 561)
(55 354)
(55 313)
(57 063)
(57 644)
(58 430)
(58 540)
(58 319)
(57 346)
(55 244)
(54 666)
(53 155)
(53 620)
(54 546)
(54 644)
(55 688)
(55 284)
(54 234)
(53 596)
(54 727)
(52 028)
(51 489)
(51 106)
(53 388)
(52 159)
(50 073)
(48 982)
(45 337)
(46 827)
(48 880)
(50 073)
(50 126)
(50 611)
(52 162)
(54 342)
(55 630)
(57 361)
(58 804)
(60 757)
Gross Profit
96 131
N/A
95 164
-1%
95 765
+1%
94 951
-1%
95 133
+0%
99 680
+5%
101 023
+1%
103 689
+3%
105 546
+2%
103 533
-2%
102 979
-1%
98 627
-4%
94 632
-4%
92 770
-2%
90 233
-3%
90 395
+0%
91 105
+1%
92 778
+2%
90 608
-2%
90 169
0%
87 904
-3%
88 681
+1%
87 119
-2%
85 933
-1%
88 806
+3%
87 604
-1%
84 482
-4%
80 444
-5%
73 754
-8%
69 173
-6%
70 562
+2%
71 255
+1%
70 278
-1%
70 067
0%
68 214
-3%
69 099
+1%
71 069
+3%
72 700
+2%
76 672
+5%
76 884
+0%
78 519
+2%
Operating Income
Operating Expenses
(73 090)
(76 041)
(77 123)
(77 935)
(78 860)
(83 253)
(78 493)
(78 152)
(77 332)
(75 803)
(75 242)
(72 531)
(68 231)
(66 464)
(64 008)
(63 762)
(68 429)
(65 838)
(65 419)
(65 636)
(65 697)
(66 403)
(66 625)
(64 910)
(64 052)
(64 877)
(62 975)
(61 911)
(61 321)
(58 502)
(58 849)
(60 394)
(60 757)
(60 730)
(60 759)
(60 556)
(60 200)
(61 101)
(61 442)
(62 013)
(63 367)
Selling, General & Administrative
(73 089)
(61 243)
(77 122)
(77 935)
(78 859)
(64 489)
(79 349)
(79 008)
(77 332)
(59 769)
(75 242)
(72 530)
(68 230)
(51 156)
(64 581)
(64 335)
(66 107)
(50 760)
(64 392)
(64 611)
(65 696)
(53 369)
(66 410)
(64 696)
(64 049)
(54 371)
(63 455)
(62 389)
(61 320)
(47 735)
(58 848)
(60 391)
(60 755)
(50 117)
(60 476)
(60 556)
(60 199)
(51 314)
(61 230)
(61 800)
(63 155)
Research & Development
0
(13 924)
0
0
0
(13 718)
0
0
0
(14 965)
0
0
0
(14 378)
0
0
0
(15 076)
0
0
0
(13 032)
0
0
0
(10 504)
0
0
0
(10 766)
0
0
0
(10 613)
0
0
0
(9 785)
0
0
0
Depreciation & Amortization
0
(873)
0
0
0
0
0
0
0
(1 068)
0
0
0
(930)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Operating Expenses
(1)
(1)
(1)
0
(1)
(5 046)
856
856
0
(1)
0
(1)
0
0
573
573
(2 322)
(2)
(1 027)
(1 025)
(1)
(2)
(215)
(214)
(3)
(2)
480
478
0
(1)
0
(3)
(2)
0
(283)
1
0
(2)
(212)
(213)
(212)
Operating Income
23 041
N/A
19 123
-17%
18 642
-3%
17 016
-9%
16 273
-4%
16 427
+1%
22 530
+37%
25 537
+13%
28 214
+10%
27 730
-2%
27 737
+0%
26 096
-6%
26 401
+1%
26 306
0%
26 225
0%
26 633
+2%
22 676
-15%
26 940
+19%
25 189
-6%
24 533
-3%
22 207
-9%
22 278
+0%
20 494
-8%
21 023
+3%
24 754
+18%
22 727
-8%
21 507
-5%
18 533
-14%
12 433
-33%
10 671
-14%
11 713
+10%
10 861
-7%
9 521
-12%
9 337
-2%
7 455
-20%
8 543
+15%
10 869
+27%
11 599
+7%
15 230
+31%
14 871
-2%
15 152
+2%
Pre-Tax Income
Interest Income Expense
8 800
9 385
9 735
10 199
9 233
7 409
5 285
2 435
782
(76)
(85)
(510)
500
1 391
1 846
2 363
1 881
1 375
1 198
1 704
1 813
3 297
3 256
2 729
3 112
2 571
1 888
2 216
1 205
1 175
3 086
2 866
3 487
3 536
4 015
5 733
5 560
4 207
3 659
3 402
4 048
Non-Reccuring Items
4 465
5 000
0
62
807
5 000
0
0
48
0
1 301
1 301
4 197
1 863
0
0
0
(1 023)
0
0
(1 023)
(139)
0
0
1 397
480
0
0
(1 129)
2
3
(277)
(278)
(280)
0
0
0
(211)
0
0
0
Gain/Loss on Disposition of Assets
(128)
(315)
(319)
(271)
(239)
(17)
9
(6)
(28)
(110)
(90)
(131)
(131)
(79)
(85)
(46)
(45)
(33)
(29)
(32)
(22)
(146)
(73)
(66)
(73)
46
47
45
254
178
175
161
(47)
(55)
68
52
18
320
220
253
292
Total Other Income
778
534
517
454
571
597
582
467
367
378
279
379
547
503
567
576
965
435
357
356
(184)
383
409
403
380
331
269
239
137
171
287
239
243
418
331
395
546
198
318
290
251
Pre-Tax Income
36 956
N/A
33 727
-9%
28 575
-15%
27 460
-4%
26 645
-3%
29 416
+10%
28 406
-3%
28 433
+0%
29 383
+3%
27 922
-5%
29 142
+4%
27 135
-7%
31 514
+16%
29 984
-5%
28 553
-5%
29 526
+3%
25 477
-14%
27 694
+9%
26 715
-4%
26 561
-1%
22 791
-14%
25 673
+13%
24 086
-6%
24 089
+0%
29 570
+23%
26 155
-12%
23 711
-9%
21 033
-11%
12 900
-39%
12 197
-5%
15 264
+25%
13 850
-9%
12 926
-7%
12 956
+0%
11 869
-8%
14 723
+24%
16 993
+15%
16 113
-5%
19 427
+21%
18 816
-3%
19 743
+5%
Net Income
Tax Provision
(14 112)
(12 166)
(10 520)
(10 009)
(9 799)
(10 431)
(9 866)
(9 636)
(9 596)
(9 993)
(10 272)
(9 344)
(10 559)
(9 443)
(8 842)
(8 831)
(7 370)
(8 367)
(7 626)
(7 475)
(6 002)
(6 294)
(6 250)
(6 332)
(8 102)
(7 244)
(6 691)
(5 991)
(3 732)
(2 764)
(3 480)
(3 084)
(2 919)
(3 093)
(2 700)
(3 286)
(3 737)
(3 987)
(4 863)
(4 739)
(4 958)
Income from Continuing Operations
22 844
21 561
18 055
17 451
16 846
18 985
18 540
18 797
19 787
17 929
18 870
17 791
20 955
20 541
19 711
20 695
18 107
19 327
19 089
19 086
16 789
19 379
17 836
17 757
21 468
18 911
17 020
15 042
9 168
9 433
11 784
10 766
10 007
9 863
9 169
11 437
13 256
12 126
14 564
14 077
14 785
Income to Minority Interest
131
(203)
(212)
(201)
(200)
(200)
(218)
(210)
(161)
(145)
(92)
(97)
(148)
(146)
(171)
(200)
(213)
(207)
(190)
(194)
(179)
(174)
(171)
(162)
(172)
(217)
(127)
(203)
(172)
(182)
(283)
(206)
(260)
(204)
(241)
(276)
(294)
(383)
(403)
(421)
(454)
Net Income (Common)
22 976
N/A
21 357
-7%
17 841
-16%
17 250
-3%
16 645
-4%
18 784
+13%
18 321
-2%
18 586
+1%
19 626
+6%
17 784
-9%
18 778
+6%
17 694
-6%
20 806
+18%
20 395
-2%
19 540
-4%
20 495
+5%
17 895
-13%
19 119
+7%
18 897
-1%
18 891
0%
16 608
-12%
19 204
+16%
17 665
-8%
17 594
0%
21 295
+21%
18 694
-12%
16 894
-10%
14 839
-12%
8 996
-39%
9 250
+3%
11 499
+24%
10 559
-8%
9 746
-8%
9 658
-1%
8 927
-8%
11 160
+25%
12 962
+16%
11 742
-9%
14 160
+21%
13 655
-4%
14 330
+5%
EPS (Diluted)
267.16
N/A
248.33
-7%
207.45
-16%
200.58
-3%
193.54
-4%
219.27
+13%
213.03
-3%
216.11
+1%
230.89
+7%
208.76
-10%
220.92
+6%
208.16
-6%
244.77
+18%
241.14
-1%
232.61
-4%
243.98
+5%
213.03
-13%
228.34
+7%
224.96
-1%
224.89
0%
198.42
-12%
229.85
+16%
213.46
-7%
212.86
0%
260.36
+22%
227.3
-13%
206.57
-9%
181.44
-12%
109.99
-39%
113.1
+3%
140.6
+24%
129.1
-8%
119.52
-7%
118.84
-1%
111.86
-6%
139.83
+25%
162.57
+16%
147.87
-9%
181.97
+23%
175.66
-3%
187
+6%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.